Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance

被引:12
|
作者
Balas, Reka Borka [1 ]
Melit, Lorena Elena [1 ]
Marginean, Cristina Oana [1 ]
机构
[1] George Emil Palade Univ Med Pharm Sci & Technol, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania
来源
CHILDREN-BASEL | 2023年 / 10卷 / 02期
关键词
Helicobacter pylori; antimicrobial resistance; children; STANDARD TRIPLE THERAPY; SECONDARY ANTIBIOTIC-RESISTANCE; CLARITHROMYCIN RESISTANCE; HIGH PREVALENCE; LEVOFLOXACIN RESISTANCE; ISRAELI CHILDREN; BABA2; GENOTYPES; INFECTION; ADOLESCENTS; ERADICATION;
D O I
10.3390/children10020403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to escape the currently used eradication regimens such as mutations that impair the replication, recombination, and transcription of DNA; the antibiotics capability to interact with protein synthesis and ribosomal activity; the adequate redox state of bacterial cells; or the penicillin-binding proteins. The aim of this review was to identify the differences in pediatric H. pylori antimicrobial-resistance trends between continents and countries of the same continent. In Asian pediatric patients, the greatest antimicrobial resistance was found to metronidazole (>50%), probably due to its wide use for parasitic infections. Aside from the increased resistance to metronidazole, the reports from different Asian countries indicated also high resistance rates to clarithromycin, suggesting that ciprofloxacin-based eradication therapy and bismuth-based quadruple therapy might be optimal choices for the eradication of H. pylori in Asian pediatric population. The scarce evidence for America revealed that H. pylori strains display an increased resistance to clarithromycin (up to 79.6%), but not all studies agreed on this statement. Pediatric patients from Africa also presented the greatest resistance rate to metronidazole (91%), but the results in terms of amoxicillin remain contradictory. Nevertheless, the lowest resistance rates in most of the African studies were found for quinolones. Among European children, the most frequent antimicrobial resistance was also noticed for metronidazole and clarithromycin (up to 59% and 45%) but with a predominance for clarithromycin as compared to other continents. The differences in antibiotic use among continents and countries worldwide is clearly responsible for the discrepancies regarding H. pylori antimicrobial-resistance patterns, emphasizing the crucial role of global judicious antibiotic use in order to control the increasing resistance rates worldwide.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Helicobacter pylori and antimicrobial resistance:: molecular mechanisms and clinical implications
    Gerrits, Monique M.
    van Vilet, Arnoud H. M.
    Kuipers, Ernst J.
    Kusters, Johannes G.
    LANCET INFECTIOUS DISEASES, 2006, 6 (11): : 699 - 709
  • [42] High Level of Antimicrobial Resistance in French Helicobacter pylori Isolates
    Raymond, Josette
    Lamarque, Dominique
    Kalach, Nicolas
    Chaussade, Stanislas
    Burucoa, Christophe
    HELICOBACTER, 2010, 15 (01) : 21 - 27
  • [43] Prevalence of antimicrobial resistance in Helicobacter pylori isolates from Iran
    Sirous, M.
    Mehrabadi, Jalil F.
    Daryani, N. E.
    Eshraghi, S.
    Hajikhani, S.
    Shirazi, M. H.
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (36): : 5962 - 5965
  • [44] Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat
    Pandya, H. B.
    Agravat, Harihar Har
    Patel, J. S.
    Sodagar, N. R. K.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (04) : 408 - 413
  • [45] Helicobacter pylori in Vegetables and Salads: Genotyping and Antimicrobial Resistance Properties
    Yahaghi, Emad
    Khamesipour, Faham
    Mashayekhi, Fatemeh
    Dehkordi, Farhad Safarpoor
    Sakhaei, Mohammad Hossein
    Masoudimanesh, Mojtaba
    Khameneie, Maryam Khayyat
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [46] Antimicrobial resistance of Helicobacter pylori.: Clinical and molecular aspects
    Vallejos, C
    Cerda, O
    Valenzuela, M
    Toledo, H
    REVISTA MEDICA DE CHILE, 2003, 131 (11) : 1313 - 1320
  • [47] Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori
    Iovene, MR
    Romano, M
    Pilloni, AP
    Giordano, B
    Montella, F
    Caliendo, S
    Tufano, MA
    CHEMOTHERAPY, 1999, 45 (01) : 8 - 14
  • [48] Antimicrobial resistance and treatment outcome for Helicobacter pylori infections in Alaska
    Bruce, M. G.
    Newbrough, D.
    Bruden, D.
    Hurlburt, D.
    Morris, J.
    Reasonover, A.
    Sacco, F.
    Hennessy, T.
    Kejka, J.
    McMahon, B.
    HELICOBACTER, 2016, 21 : 83 - 84
  • [49] Overcoming the effects of increasing antimicrobial resistance on Helicobacter pylori therapy
    Graham, David Yates
    Rokkas, Theodore
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (11) : 705 - 711
  • [50] Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany
    Wueppenhorst, Nicole
    Draeger, Sarah
    Stueger, Hans Peter
    Hobmaier, Beate
    Vorreiter, Jolanta
    Kist, Manfred
    Glocker, Erik-Oliver
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (11) : 3127 - 3133